PRF Technologies PRFX
NASDAQ PRFX
$1.00 -0.01 (-0.99%)
At close: Aug 20, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Operating Leases (2023 - 2025)

PRF Technologies' (PRFX) quarterly Operating Leases came in at $56000.0 in Q2 2025, down 1.75% YoY from $57000.0 in Q2 2024, and up 24.44% on a QoQ basis from $45000.0 in Q4 2024.

PRF Technologies (PRFX) Operating Leases (2023 - 2025) Analysis & Trends

PRF Technologies (PRFX) has 3 years of Operating Leases data on file, last reported at $56000.0 in Q2 2025.

  • Quarterly Operating Leases fell 1.75% year-over-year to $56000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $56000.0 (down 1.75% YoY) and the FY2024 annual result came in at $45000.0, up 50.0% from the prior year.
  • Operating Leases improved to $56000.0 in Q2 2025, from $45000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $57000.0 in Q1 2024 to a low of $30000.0 in Q4 2023.
  • A 3-year average of $50000.0 and a median of $55500.0 in 2023 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2024 — Operating Leases jumped 50.0% — and 2025, when it fell 1.75%.
  • Tracing PRFX's Operating Leases over 3 years: stood at $30000.0 in 2023, then jumped by 50.0% to $45000.0 in 2024, then grew by 24.44% to $56000.0 in 2025.
  • The last three Operating Leases figures came in at $56000.0 (Q2 2025), $45000.0 (Q4 2024), and $57000.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 PRF Technologies 654,452.72 -3.49 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 56,000.00
Dec 31, 2024 45,000.00
Jun 30, 2024 57,000.00
Mar 31, 2024 57,000.00
Dec 31, 2023 30,000.00
Sep 30, 2023 55,000.00